ArticleMaterials today. Bio2026
3D bioprinted composite scaffold incorporating microfluidics-derived chondrocyte microspheroids promotes auricular cartilage regeneration.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioprinting in Tissue Repair and Its ENT Applications.Polymers · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microtia remains a major clinical challenge, as autologous costal cartilage transplantation-the current gold standard-suffers from donor-site morbidity and imprecise morphology, whereas synthetic implants are prone to immune rejection and structural collapse. Here, we present a biphasic composite strategy integrating microfluidics and 3D bioprinting. Organoid-like auricular spheroids generated via microfluidics exhibited a biomimetic architecture, featuring cartilage-specific collagen cores surrounded by organized chondrocytes, with sustained ECM secretion and phenotype maintenance. These bioactive spheroids were subsequently incorporated into a biomimetic bioink and patterned through extrusion-based 3D bioprinting, enabling precise anatomical shaping and functional scaffold construction. Upon implantation in immunodeficient mice, the biphasic constructs promoted rapid in situ cartilage regeneration and ECM deposition, yielding tissue with morphological and histological features closely resembling native auricular cartilage. Collectively, this study demonstrates that the integration of microfluidic spheroids with 3D bioprinting offers a balanced solution between structural fidelity and biological functionality, providing a promising pathway for auricular cartilage reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.